More Than 25,000 Bottles of Blood Pressure Medication Recalled

The U.S. Food and Drug Administration has announced a recall of more than 25,000 bottles of prescription blood pressure medication after the chlorthalidone tablets failed dissolution testing meant to confirm the drug releases properly. The recall covers 25-milligram chlorthalidone tablets manufactured by Inventia Healthcare Limited in India. FDA says the tablets did not meet dissolution specifications, a factor that can affect how quickly and how much active ingredient is absorbed, potentially reducing effectiveness. The total number of bottles reflects two recalls issued this year: 11,460 in June and 13,567 in September, totaling 25,027. Affected bottles are 100- or 1,000-tablet containers with an expiration date of April 2027. The FDA classified it as Class II and advises patients not to stop without consulting a healthcare professional.